AZTR: Planning 2nd Site for ATR-12 Trial [Yahoo! Finance]
Azitra Inc (AZTR)
Company Research
Source: Yahoo! Finance
Azitra, Inc. (NYSE:AZTR) reported third quarter results in mid-November highlighting its $10 million raise back in July, dosing of the first patient in the Netherton syndrome trial, investigational new drug (IND) clearance from the FDA for ATR-04 and the issuance of new patents during the reporting period. Other updates since our last report include Azitra management participating in several investor and industry conferences and the FDA's grant of fast-track designation for skin rash from EGFR inhibitors. Operational and Financial Results Azitra reported 3Q:24 results in a press release and Form 10-Q filing with the SEC on November 12 th . For the third quarter of 2024 ending September 30, 2024 and versus the prior year's comparable period, revenues of $0 were reported compared with $311,000 in the prior year. Net loss for the quarter totaled ($1.0) million or ($0.17) per share. Operational expenses rose 47% as increases in both research and development (R&D) expenses and general
Show less
Read more
Impact Snapshot
Event Time:
AZTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZTR alerts
High impacting Azitra Inc news events
Weekly update
A roundup of the hottest topics
AZTR
News
- Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates [Yahoo! Finance]Yahoo! Finance
- Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesPR Newswire
- Azitra to Present at BIO-Europe 2024Business Wire
- Azitra to Participate in the 2024 Maxim Healthcare Virtual SummitBusiness Wire
- Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology CongressBusiness Wire
AZTR
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- AZTR's page on the SEC website